title: The mitogen-activated protein kinase pathway for molecular-targeted cancer treatment.
authors.affiliation: Pfizer Global Research and Development, Michigan Laboratories, Ann Arbor 48105, USA.
authors.forename: Judith S
authors.initials: JS
authors.lastname: Sebolt-Leopold
authors.forename: Roman
authors.initials: R
authors.lastname: Herrera
authors.forename: Jeffrey F
authors.initials: JF
authors.lastname: Ohren
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018450:Disease Progression; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D020928:Mitogen-Activated Protein Kinases